Cas:4110-44-5 3,3-Dimethyloctane manufacturer & supplier

We serve Chemical Name:3,3-Dimethyloctane CAS:4110-44-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,3-Dimethyloctane

Chemical Name:3,3-Dimethyloctane
CAS.NO:4110-44-5
Synonyms:3,3-Dimethyloctane;Octane,3,3-dimethyl;3,3-DIMETHYL OCTANE;3,3-Dimethyl-octan;MFCD00048874;Octane, 3,3-dimethyl-
Molecular Formula:C10H22
Molecular Weight:142.282
HS Code:2901100000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:161.0±7.0 °C at 760 mmHg
Density:0.7±0.1 g/cm3
Index of Refraction:1.414
PSA:
Exact Mass:142.172150
LogP:5.70

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3295
Packing Group:III


Contact us for information like 3,3-Dimethyloctane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Octane, 3,3-dimethyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00048874 Use and application,3,3-DIMETHYL OCTANE technical grade,usp/ep/jp grade.


Related News: The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. 3,3-Dimethyloctane manufacturer Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged. 3,3-Dimethyloctane supplier The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. 3,3-Dimethyloctane vendor It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. 3,3-Dimethyloctane factory Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged.